Trazimera (trastuzumab-qyyp) is used to treat stomach and breast cancer. Trazimera is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Trazimera may be covered by your Medicare or insurance plan.